ストックスクリーナーアプリを入手
0.6695
1.22%
0.0081
アフターアワーズ：
29.72
29.05
+4,339%
前日終値:
$0.6614
開ける：
$0.652
24時間の取引高:
328.94K
Relative Volume:
1.11
時価総額：
$22.22M
収益：
-
当期純損益:
$-98.79M
株価収益率:
-0.2047
EPS:
-3.27
ネットキャッシュフロー:
$-51.66M
1週間 パフォーマンス:
+9.31%
1か月 パフォーマンス:
+3.53%
6か月 パフォーマンス:
+142.66%
1年 パフォーマンス:
-75.39%
1日の値動き範囲:
$0.612
$0.6912
1週間の範囲:
$0.59
$0.6912
52週間の値動き範囲:
$0.2404
$3.98
Relmada Therapeutics Inc Stock (RLMD) Company Profile
名前
Relmada Therapeutics Inc
セクター
電話
646 876 3459
住所
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
RLMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 3.03 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.585 | 1.86B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.42 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.64 | 118.42M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.47 | 360.07M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.25 | 0 | 0 | 0 | 0 | 0.00 |
Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-05 | ダウングレード | Mizuho | Outperform → Neutral |
| 2024-09-17 | アップグレード | Jefferies | Hold → Buy |
| 2024-06-05 | ダウングレード | Goldman | Neutral → Sell |
| 2022-10-14 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-14 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-10-14 | ダウングレード | Truist | Buy → Hold |
| 2022-10-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-11-18 | 開始されました | Mizuho | Buy |
| 2021-05-20 | 再開されました | Goldman | Buy |
| 2020-10-28 | ダウングレード | Goldman | Buy → Neutral |
| 2020-07-14 | 開始されました | Oppenheimer | Outperform |
| 2020-05-04 | 開始されました | SunTrust | Buy |
| 2020-04-21 | 開始されました | Goldman | Buy |
| 2020-01-27 | 開始されました | Jefferies | Buy |
| 2020-01-10 | 開始されました | SVB Leerink | Outperform |
| 2019-12-16 | 開始されました | Guggenheim | Buy |
すべてを表示
Relmada Therapeutics Inc (RLMD) 最新ニュース
What MACD signals say about Relmada Therapeutics Inc.2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Is it too late to sell Relmada Therapeutics Inc.Options Play & Weekly Return Optimization Plans - Newser
Price momentum metrics for Relmada Therapeutics Inc. explainedJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
Is Relmada Therapeutics Inc. a candidate for recovery playJuly 2025 Trends & AI Based Buy/Sell Signal Reports - Newser
Is it time to cut losses on Relmada Therapeutics Inc.July 2025 Breakouts & AI Optimized Trade Strategies - Newser
Advanced analytics toolkit walkthrough for Relmada Therapeutics Inc.July 2025 Institutional & Growth Focused Entry Reports - Newser
Relmada Therapeutics Inc. stock trend outlook and recovery path2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Best data tools to analyze Relmada Therapeutics Inc. stockGap Up & Fast Entry Momentum Trade Alerts - Newser
Statistical indicators supporting Relmada Therapeutics Inc.’s strengthTrade Performance Summary & Growth Focused Stock Pick Reports - Newser
Analyzing Relmada Therapeutics Inc. with multi timeframe chartsWeekly Gains Report & Smart Money Movement Tracker - Newser
Market reaction to Relmada Therapeutics Inc.’s recent news2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Is a relief rally coming for Relmada Therapeutics Inc. holdersQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
Chartists See Breakout Potential in Relmada Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Using AI based signals to follow Relmada Therapeutics Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - Newser
How to integrate Relmada Therapeutics Inc. into portfolio analysis toolsWeekly Trade Report & Verified Technical Trade Signals - Newser
What data driven models say about Relmada Therapeutics Inc.’s futureQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser
Should you wait for a breakout in Relmada Therapeutics Inc.July 2025 Reactions & Accurate Buy Signal Alerts - Newser
Tools to assess Relmada Therapeutics Inc.’s risk profileJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Evaluating Relmada Therapeutics Inc. with trendline analysisMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser
What’s next for Relmada Therapeutics Inc. stock pricePortfolio Update Summary & Entry Point Strategy Guides - Newser
Relmada Therapeutics Inc. stock momentum explainedEarnings Risk Summary & Short-Term Trading Alerts - Newser
Is Relmada Therapeutics Inc.’s growth already priced inJuly 2025 Momentum & Low Drawdown Investment Ideas - sundaytimes.kr
Published on: 2025-08-23 21:25:05 - Newser
What is Relmada Therapeutics Inc. s revenue forecastWeekly Earnings Recap & Risk Managed Trade Strategies - theviewers.co.kr
Aug Catalysts: Can Relmada Therapeutics Inc. maintain its current growth rateEarnings Risk Report & Fast Gaining Stock Strategy Reports - theviewers.co.kr
Will Relmada Therapeutics Inc. benefit from macro trendsJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Machine Learning Models Forecast Relmada Therapeutics Inc. UptickPortfolio Return Summary & Consistent Profit Trade Alerts - kangso.co.kr
Why Relmada Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru
Recovery Setup Building in Relmada Therapeutics Inc. Experts SayQuarterly Market Review & Community Shared Stock Ideas - beatles.ru
When is the best time to exit Relmada Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - Newser
Will Relmada Therapeutics Inc. price bounce be sustainable2025 Biggest Moves & Precise Buy Zone Identification - Newser
Relmada Therapeutics Inc (RLMD) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):